Retrospective analysis of the safety profile and clinical, radiological and PSA evolution in metastatic castration resistant prostate cancer (MCRPC), chemotherapy naïve patients treated with abiratarone acetate (AA)

✍ Scribed by Couselo Paniagua, M.; López Carrizosa, M.; Samper Ots, P.; Zapatero Ortuño, J.; Jerviz Guía, V.; Ibañez Villoslada, C.; Saez Garrido, J.; Dominguez Morcillo, M.; Martin de Miguel, M.

• Book ID: 122934438
• Publisher: Wielkopolskie Centrum Onkologii
• Year: 2013
• Tongue: Polish
• Weight: 60 KB
• Volume: 18
• Category: Article
• ISSN: 1507-1367
• DOI: 10.1016/j.rpor.2013.03.518